Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • With Gluten or Gluten...

    With Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence of Gluten

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-03T17:04:40+05:30  |  Updated On 3 Dec 2018 5:04 PM IST
    With Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence of Gluten
    Drugmakers may be asked to declare whether a drug is gluten-free

    New Delhi: Following the move to have labelling identifying the presence of gluten in foods, it is likely that the presence of Gluten in drugs and medicines will also have to be mentioned on the labelling on the packaging.

    The move will indeed bring a sigh of relief from thousands of patients suffering from celiac diseases as well as other forms of gluten intolerance, as they would be forwarned before consuming a medicine

    According to experts at the AIIMS, celiac disease affects close to six to eight million people in India.

    A recent report in Livemint pointed out that issue is on the agenda of the Drug's Technical Advisory Board that met recently.

    Gluten is a mixture of proteins found in wheat, barley, rye and derivatives. Celiac disease is one of the most common chronic, immune-mediated disorders, triggered by its consumption. The body overreacts to the mixture and damages the finger-like structure along the walls of the small intestine.

    Besides Drug's Technical Advisory Board's decision to label a drug gluten-free, All India Institute of Medical Sciences(AIIMS) has suggested the board after recommendations by the department of physical medicines and rehabilitation to make alterations in the law and instruct drugmakers to avoid usage of agents containing gluten.

    In 2017, USFDA also drafted a guidance which intended to convey the drug manufacturers to label drugs containing gluten, a matter of interest to individuals with celiac disease. Some individuals with celiac disease have faced difficulty when trying to determine whether specific drug products contain gluten. Confronted by uncertainty, some patients may forego important medication rather than risk an adverse reaction to gluten. Thus, even if gluten is not present at levels that would harm a typical individual with celiac disease, that individual may be harmed through uncertainty and lack of information.

    The matter has also now been taken by the Indian Counterpart. Two people aware of the matter told live mint on condition of anonymity, “We have to consider the potential impact on those individuals with celiac disease, who take multiple oral medications each day. Patients sensitive to gluten would want to eliminate all sources of ingested gluten and hence minimise exposure. The Drug Technical Advisory Board will take up the matter and if approved, drug firms will be encouraged to revise their labelling to use the statement.”

    Also Read:Labelling norms for high-risk medicines made Stringent, Check out details
    allergyceliaccompositiondrug labellingdrug packagingDrug Technical Advisory BoardDTABglutenkarnataka druglabellingpackagingpharmaside effectssunil attavarUSFDA
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok